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Abstract—This study aims to evaluate the feasibility of 
metabolite profiling for the characterisation and discrimination 
volatile compounds using the pattern recognition from in vitro 
cancer cell lines, which are lung, breast and colon cancer 
together with the blank medium as a control group. This study 
implemented the A549 (lung), MCF7 (breast) and HCT116 
(colon). Cells were harvested and maintained until they grow as 
monolayer adherent and reach confluence 70-90% before 
sampling. The volatiles profile from the targeted cell line was 
established using headspace solid phase microextraction 
coupled to gas chromatography-mass spectrometry (HS-
SPME/GCMS). Multivariate data analysis employed principal 
component analysis (PCA) to better visualise the subtle 
similarities and the differences among these data sets. A total of 
116 volatile organic compounds were detected focused on a 
limited range of retention time from 3rd until 17th minutes, and 
33 compounds were recognized as targeted compounds (peak 
area>1%). According to both results, the score and the loading 
plot explained 83% of the total variance. The volatiles 
compound has shown to be significantly distinguished among 
cancerous and control group based on metabolite profiling using 
pattern recognition approach.  
 
Index Terms—GCMS; Headspace SPME; In Vitro Cell Line; 




According to the world statistic, the most prevalent cause of 
cancer-related death among men and women are lung, breast 
and colorectal [1][2]. Cancer itself derived from the 
dysfunction of the immune system [3]. More specifically, it 
started when cells begin to grow irregularly and become an 
abnormal population growth when cells multiply 
considerably [4]. Metabolomics can be defined as a field of 
research that aims the study of the metabolites from chemical 
process [5] presents within the cell, tissue or organism. The 
methods for metabolomics application are mostly focused on 
the analytical techniques which utilise Mass Spectrometry 
(MS) and Nuclear Magnetic Resonance (NMR) spectroscopy 
[6]. For the diagnostic purpose, metabolites obtained from the 
metabolomics technique have been used for the compounds 
determination. Volatile compounds from cancer cell lines as 
being investigated in this study indirectly provide the 
predictive signature for cancer biomarker based on the 
metabolites emitted [7]. Metabolomics study defined three 
major steps which emphasised targeted analysis, metabolite 
profiling, and metabolomics fingerprinting [8]. To date, 
metabolite profiling has become an emerging technique for 
cancer diagnosis because of non-invasive and potentially 
inexpensive. The application for volatiles compound 
production was executed using headspace solid phase 
microextraction coupled to gas chromatography-mass 
spectrometry (HS-SPME/GCMS) [9]. Additionally, volatile 
organic compounds can be described as an organic chemical 
which carbon-based with high vapour pressure and at 
ordinary room temperature [10]. Currently, this technique 
revealed the study of differences between cancer cell lines 
based on volatile compounds to be associated with the early 
diagnostic which instigated the analytical study [11]. As 
believed, the particular cell lines will discover the unique 
pattern of the metabolite profiling promoting the signature for 
cancer biomarker [12]. As a consequence, a preliminary study 
for classification of volatile compounds among the cancer 
cell lines needs further investigation before subjected to the 
biomarker discovery subsequently.  
Hence, a multivariate statistical analysis which employed 
the principal component analysis has been a promising tool 
to differentiate samples from chromatographic methods [13]. 
It was reported that volatiles profile had been studied to 
discover the pattern from the different type of cancer and 
present the similarity utilising pattern recognition method 
[14]. Furthermore, in a study of characterisation of breast 
cancer [15], they have shown the potential to distinguish 
among cancerous and non-cancerous by employing the 
Principal Component Analysis (PCA) and Partial Least 
Square Discriminant Analysis (PLS-DA) techniques which 
presented high accuracy and specificity. There are few reports 
published based on volatile compounds in Eugenia Uniflora 
leaves sample which discriminated their biotypes orange, red 
and purple groups using HS-SPME by the methods of 
hierarchical clustering analysis (HCA) and PCA [16]. 
Presently, in a publication of apple classification [17], 
chemometric analysis has been a successful technique in 
differentiating samples related with SPME-GCMS. Besides, 
previous studies have shown the identification of biomarkers 
implemented the lung, colon, breast and ovarian from the 
metabolomics and significantly classified using the 
multivariate analysis [18]. The purpose of this work was thus 
first to employ the metabolite profiles for the characterisation 
of volatile compounds from three different cancer cell lines 
and blank medium as a control using pattern recognition 
approach.  
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II. MATERIALS AND METHODS  
 
A. Cell Lines and Culture Conditions 
Three cancer cell lines employed for metabolic profiling 
analysis were obtained from Cell and Tissue Culture 
Engineering Lab, Department of Biotechnology Engineering, 
IIUM. Namely the A549 (ATCC CCL-185) human lung 
epithelial cell line, the HCT116 (ATCC CCL-247) human 
colorectal carcinoma cell line and the MCF7 (ATCC HTB-
22) human breast adenocarcinoma cell line. A control group 
was provided with the blank medium containing no cells for 
each. Morphology condition which is epithelial from the cell 
lines designation was highlighted as the primary selection for 
this study. The cells were revived and cultured in growth 
medium included 90% DMEM (Dulbecco’s Modified Eagles 
Medium) supplemented with 10% (v/v) FBS (Fetal Bovine 
Serum) as growth supplements. The cells were cultured and 
maintained in T-25cm2 flasks in 5ml culture medium, under 
standard conditions in an incubator at 37°C/, 5% CO2. The 
cells were grown and incubated until 70-90% confluence 
before the next subculture process. A549 cell line took two 
days to reach the confluence, while for HCT116 and MCF7 
cell lines were incubated for three days respectively. 
Hereafter, once reach the confluence, all cell lines were 
undergone to the next passage with seeding of an initial cell 
density of 5×105 cells/ml in T-25cm2 flasks separately in 5ml 
new medium. They were cultured and incubated until cells 
reached 70-90% confluence for almost two to four days. The 
culture was inspected daily for any signs of contamination.  
 
B. Headspace Analysis by SPME GCMS 
A divinylbenzene-carboxy-polydimethylsiloxane which is 
known as (DVB/CAR/PDMS) was used in the SPME 
extractions. The matrix has been shown to be an effective 
fibre coating [19] based on its high percentage of abstraction 
(achieving more than 100 volatile compounds) as well as its 
relatively good affinity between the compounds and the fibre 
[20][21]. The complex mixtures were evaluated using a GC-
MS system (Agilent Technologies) under the following 
conditions: DB-WAX column (30m × 250µm × 0.25µm); 
helium gas flow: 1.18 mL/min; Oven program: 50°C for 0.5 
min, then 10°C/min to 250°C for 5 min; temperature program 
250°C; injection volume 1µL and mode split less [22]. Same 
parameter settings were for all runs. Upon reaching cell 
confluence of 70-90%, the SPME fibre was introduced into 
the headspace culture flask for 15 minutes in the incubator. 
Before sampling, the fibre was preconditioned in a GC 
injection port at 250°C for 8 minutes to clear localised 
background effects before any sampling. Then, the needle 
was injected into the GC injector at 250°C within 2 minutes 
splitless time. After 5 minutes, the injector was removed to 
avoid fibre damage. However, the samples were left to run in 
the GCMS system for about 24 minutes to complete the 
extraction time for metabolites production.  
 
C. Statistical Analysis  
Multivariate data analysis was applied to discover the 
potential difference of unique pattern from in vitro cancer cell 
lines. A total of 116 volatile compounds were tentatively 
recognised and evaluated. A data matrix consisted of the peak 
areas of all samples (3rd to 17th minutes of retention time) 
were subjected to the Principal Component Analysis (PCA) 
which utilised STATISTICA ver. 10.0 and The Unscramble 
X ver. 10.5. PCA was considered as an unsupervised method 
to explain the variance information of data and to establish 
the relationship between samples (score plot) and the peak 
area of volatile compounds (loading plot) [23][24][25]. This 
technique was instigated to perform a classification of cell 
lines based on their volatiles profile. 
III. RESULTS AND DISCUSSIONS 
 
A. Characterization of Volatile Compounds for Cell 
Lines   
A total of 116 volatile compounds were discovered, 
containing the total area of the peaks revealed from A549 
(34%), MCF7 (21%), HCT116 (55%) and blank medium 
(6%) respectively. Out of 116 volatiles, 33 VOCs were 
recognised as targeted compounds which the peak area is 
greater than 1% and employing spectral library matching 
(higher than 80% match) as presented in Table 1. Figure 1 
shows the chromatograms of the volatile characteristic profile 
of all samples. Volatiles were identified through the National 
Institute of Standards and Technology (NIST 2009) mass 
spectral database and retention time libraries. The 
chromatographic region between 3 and 17 minutes was 
modelled and selected. It was reported that compounds 
recognised after 17th minutes were considered as noise which 
the patterns can be seen from chromatograms in Figure 1. It 
can be valued that clear variances exist in pattern profiles 
between cancer cell line and blank medium. The differences 
in volatile profiles may be attributed to the dissimilarity of the 
relative concentration from these complexes in the vapour 
phase. Besides, there a few factors that result in variation 
composition which are extraction time, extraction 
temperature, incubation time and the background influence 
during the running sample process [26].  
Different cell lines emit different volatile compounds that 
could be used as biomarkers for diseases. The similar peak 
may be detected due to the same compound emitted during 
the extraction time. Table 1 shows that styrene has been found 
in all samples at the specific retention time respectively; 
A549 (5.5636, 5.7082, 5.8548, and 5.9093 minutes), HCT116 
(5.7751 minutes), MCF7 (5.7540 minutes) and Blank 
medium (5.7396 minutes). This finding suggests that styrene 
could be a degradation product of the polystyrene flask. A 
similar finding has been reported in a previous study [27]. 
Meanwhile, Ethylbenzene was only found in A549, HCT116, 
and MCF7 cell line between 3.92 and 4.32 minutes, whereas 
Benzaldehyde present only in the blank medium at 8.9957 
minutes. This compound of Benzaldehyde may probably be 
metabolised by the cells as reported in the previous study of 
human skin cell line[28] and also found from volatile 
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Retention Time  
(min) 
A549 HCT116   MCF7   BLANK MEDIUM 
3.9272 Ethylbenzene    
4.2307        Ethylbenzene                                         
4.3273  Ethylbenzene                                     
5.5636                              Styrene                                               
5.7082 Styrene                                               
5.7396    Styrene 
5.7540   Styrene                                               
5.7751  Styrene                                          
5.8548 Styrene    
5.9093 Styrene    
6.0517  Dodecane                                          




   
7.5413   Cyclohexanol  
8.3524 
Benzene,1,3 –  
bis(1,1-dimethylethyl) 









8.6793    Tetradecane 
8.6814 Tetradecane                                            
8.7461   1-Hexanol, 2-ethyl-  
8.7819  Tetradecane            
8.9957    Benzaldehyde 
9.5510                          Tetradecane                                          
10.2087   Silanediol, dimethyl-                               
10.2213                                Silanediol, dimethyl-   
10.2570                                  Silanediol, dimethyl- 
10.2634                  Silanediol, dimethyl-    
10.9233                                  
2-Pyrrolidinone,  
1-methyl 
11.2942           
2-Amino-5-
methylbenzoic acid                      
   
11.5392                                 
Oxime-,  
methoxy-phenyl-                            
 
11.5561                                  
Oxime-,  
methoxy-phenyl- 
11.5562            
Oxime-,  
methoxy-phenyl- 
   
16.9055            
Oxazolidine,  
2-ethyl-2,3-dimethyl- 
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Figure 1: VOC chromatograms (Abundance versus Time (minutes)) obtained using the HS-SPME/GCMS method. 
(a) A549 (lung cancer), (b) MCF7 (breast cancer),  
(c) HCT116 (colon cancer), and (d) Blank medium
(c) 
(d) 
Journal of Telecommunication, Electronic and Computer Engineering 
68 e-ISSN: 2289-8131   Vol. 10 No. 1-16  
B. Multivariate Data Analysis 
The principal component analysis was applied to explore 
the proficiency of the HS-SPME/GCMS in distinguishing the 
cell lines and blank medium based on their volatile 
compounds profile. Total variance of 83% explained the 
distribution of the data. Figure 2 shows scatter plot of normal 
probability; which is important in identifying the fundamental 
departures from normality [13]. It was found that all samples 
were fit to the straight line suggesting that the data fit the 
distribution. Meanwhile, Figure 3 presents matrix plots graph 
which visualising a dispersion of data associated with 
retention time separately. The number of metabolites 
considerably increased as the incubation time increased. In 
another factor, VOCs were undergoing pre-conditioning 
phase to enrich the metabolites detection of interest. The 
conception of scattered data highlighted the HCT116 (colon 
cancer) contributes the most spreading data among other 
cells. The last influence was from the blank medium which 
can be concluded that compounds without cells not much 
consumed during the adsorption time [30]. The second most 
dispersion of the data was A549 (lung cancer), followed by 
the MCF7 (breast cancer). Even though the cancer cells 
emitted quite similar volatiles, but to be specific, it is of vital 
importance to explore the particular compounds for cancer 
biomarkers study.  
 




































Figure 3: Matrix plot of the distribution of confluence cells 
 






Figure 5: PCA model for loading plot of VOCs profiles 
 
Figure 4 shows PCA score plot model results of the first 
three principal components. The variance of PC1, PC2, and 
PC3 were 36%, 29%, and 18% correspondingly, representing 
83% of the total VOCs of variability data. PCA offers a 
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picturing of three main components definite and relatively 
grouping models concerning different colours designated 
from all samples. Figure 5 shows PCA loading plot which is 
related to the correlation of variables. Each variable 
constituted of retention time respectively and associated with 
the recognised compounds for all samples. S1 until S5 label 
designated from the range of retention time; S1 (3 to 5.9 
minutes), S2 (6 to 8.9 minutes), S3 (9 to 11.9 minutes), S4 
(12 to 14.9 minutes) and S5 (15 to 17 minutes). The scores in 
PC1, which describes 36% of the total variance, present the 
clustering with the A549 (blue), HCT116 (green), and MCF7 
(black) is outlined in PC1 positive and associated closely. 
Meanwhile, the group respected to the blank medium (red), is 
nominated with a separation in PC1. The loading plot model 
shows that volatiles emitted attributed to the retention time of 
S1, S4, and S5 are responsible for the discrimination of A549, 
HCT116, and MCF7which volatile compounds produced 
from S2 and S3 of retention time are attributed to the blank 
medium. This finding suggests the compounds released are 
mostly consumed by cells [31] after minutes of 12th and 
within 3rd to 5th minutes subsequently.  
In conjunction with PC2, the total variance explained 29% 
shows that the grouping of the blank medium is visualised 
positively in PC2, while the cluster of A549, HCT116, and 
MCF7 are calculated in negative PC2. From the loading plot, 
it indicates that the compounds emitted from S2 and S3 of 
retention time comprised of the blank medium the most, 
hence, created a distance from other cell lines as projected in 
PC2. Based on the score plot, the compounds were 
overlapped with the A549, HCT116 and MCF7 samples 
resulted from the similar compounds produced [32] namely 
ethylbenzene, styrene, silanediol, dimethyl- and tetradecane. 
Thus, our results defined that those compounds were close to 
each other due to the same VOCs produced and may have a 
close association with the retention time respectively. Even 
though the differences in samples are well illustrated, the 
clustering tendencies by the metabolites emitted are not easily 
distinguishable for the predictive signature for each cancer 
cell line.  
 
IV. CONCLUSION  
 
A simple method was developed to establish the 
visualisation and discrimination from the volatile compounds 
profiles in A549, HCT116, MCF7 and blank medium based 
on the identified compounds utilising HS-SPME/GCMS 
method. The acceptable percentage which is about 83% of the 
total VOCs variability has been observed well from the PCA 
score plot and loading plot. The application of PCA as 
chemometric tools for the preliminary study provides a 
picturing of discrimination between the samples. A good 
separation of blank medium and other cells confirmed the 
pattern observed with and without cells. Nevertheless, further 
studies using different multivariate data analysis are 
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